← Back to headlines
Adaptive Biotech Reports 35% Revenue Growth in Q1 2026
Adaptive Biotech (ADPT) announced a significant 35% increase in revenue for the first quarter of 2026, primarily driven by the strong performance of its clonoSEQ product.
3 Jun, 18:00 — 3 Jun, 18:00
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Restaurant Group Denies Anti-Israel Boycott Caused Closures
just now
Metro Manila Workers to Receive First Tranche of Wage Hike on July 25
just now
Riga Forecasts Increased Tourist Numbers, Industry Criticizes State Tourism Development
just now